Ed Borkowski
Director/Board Member chez FIRST WAVE BIOPHARMA, INC.
Fortune : 210 $ au 31/03/2024
Profil
Edward J.
Borkowski currently works at Instadose Pharma Corp.
(Canada), as Vice Chairman from 2022, Acacia Pharma Ltd., as Non-Executive Director from 2018, First Wave Biopharma, Inc., as Lead Independent Director from 2015, Acacia Pharma Group Ltd., as Independent Non-Executive Director from 2018, Nexcella, Inc., as Director from 2023, The American Institute of Certified Public Accountants, as Member, Mylan Institutional, Inc., as Vice President, Allegheny College, as Trustee, and New York State Society of Certified Public Accountants, as Member.
Mr. Borkowski also formerly worked at Benchmark Federal Credit Union, as Director from 1996 to 1999, WhereverTV, Inc., as Director, WhereverTV Broadcasting Corp., as Director, Co-Diagnostics, Inc., as Independent Director from 2017 to 2019, Transdermal Delivery Solutions Corp., as Director, Instadose Pharma Corp., as Director, Actylis Corp., as Chief Financial Officer in 2018, Wyeth LLC, as Comptroller from 1992 to 1999, Merck & Co., Inc., as Engagement Manager, Mylan Laboratories, Inc., as Chief Financial Officer from 2002 to 2007, Mylan, Inc., as Chief Financial Officer from 1999 to 2009, CareFusion Corp., as Chief Financial Officer from 2009 to 2010, Mylan NV, as Chief Financial Officer & Executive Vice President, Arthur Andersen LLP, as Principal, Pharmacia Corp., as VP-Global Finance & Information Technology, ConvaTec, Inc., as Chief Financial Officer from 2012 to 2013, MiMedx Group, Inc., as Chief Financial Officer from 2019 to 2020, Convatec Healthcare B SARL, as Chief Financial Officer, TherapeuticsMD, Inc., as Executive Vice President-Operations, Amerigen Pharmaceuticals Ltd., as Chief Financial Officer from 2013 to 2016, Advanz Pharma Corp.
Ltd., as Chief Financial Officer from 2015 to 2018, and Convatec Group Plc, as Chief Financial Officer from 2012 to 2013.
Mr. Borkowski received his undergraduate degree from Allegheny College and Masters Business Admin degree from Rutgers Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/10/2023 | 48 ( inf% ) | 210 $ | 31/03/2024 |
Postes actifs de Ed Borkowski
| Sociétés | Poste | Début |
|---|---|---|
| ACACIA PHARMA GROUP PLC | Director/Board Member | 01/03/2018 |
| FIRST WAVE BIOPHARMA, INC. | Director/Board Member | 01/05/2015 |
| Allegheny College | Director/Board Member | - |
Acacia Pharma Ltd.
 Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 01/01/2018 |
Mylan Institutional, Inc.
 Mylan Institutional, Inc. Pharmaceuticals: MajorHealth Technology Mylan Institutional, Inc. provides unit dose generic pharmaceuticals to hospitals and other institutions. The firm offers health care equipment and medical line of burn care products. The company was founded in 1980 and is headquartered in Rockford, IL. | Corporate Officer/Principal | - |
New York State Society of Certified Public Accountants
 New York State Society of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services New York State Society of Certified Public Accountants is a non-profit organization. It provides a membership program for certified public accountants that offers in-person and online networking opportunities, Continuing Professional Education courses and conferences, the CPA Journal, and other publications. The company was foudned in 1897 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Corporate Officer/Principal | - |
Nexcella, Inc.
 Nexcella, Inc. BiotechnologyHealth Technology Part of Immix Biopharma, Inc., Nexcella, Inc. is a clinical-stage biopharmaceutical company based in Los Angeles, CA. The private company is engaged in the discovery and development of novel cell therapies for oncology and other indications. Nexcella's lead candidate, next generation bcma-targeted car-t nxc-201, has produced high response rates in relapsed/refractory al amyloidosis and relapsed/refractory multiple myeloma, and has been awarded orphan drug designation by the FDA in both indications. The company's n-genius platform allows for the discovery, development, and manufacture of cutting-edge cell therapies for patients in need. Expansion into autoimmune indications is planned. | Director/Board Member | 22/06/2023 |
Anciens postes connus de Ed Borkowski
| Sociétés | Poste | Fin |
|---|---|---|
| THERAPEUTICSMD, INC. | Chief Operating Officer | 30/09/2021 |
| ░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░░ ░░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Ed Borkowski
| Allegheny College | Undergraduate Degree |
| Rutgers Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 7 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| CO-DIAGNOSTICS, INC. | Health Technology |
| MIMEDX GROUP, INC. | Health Technology |
| CONVATEC GROUP PLC | Health Technology |
| THERAPEUTICSMD, INC. | Health Technology |
| FIRST WAVE BIOPHARMA, INC. | Health Technology |
| INSTADOSE PHARMA CORP. | Process Industries |
| Entreprise privées | 18 |
|---|---|
Actylis Corp.
 Actylis Corp. Pharmaceuticals: GenericHealth Technology Actylis Corp. engages in the development, marketing, sale, and distribution of chemical compounds used in the pharmaceutical, nutraceutical, agricultural, coatings, and industrial chemical industries. It operates through the following segments: Human Health, Pharmaceutical Ingredients, and Performance Chemicals. The Human Health segment develops and sells finished dosage form generic drugs and nutraceutical products. The Pharmaceutical Ingredients segment supplies active pharmaceutical ingredients and pharmaceutical intermediates. The Performance Chemicals segment comprises of specialty chemicals and agricultural protection products. The company was founded in 1947 and is headquartered in Port Washington, NY. | Health Technology |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Mylan Laboratories, Inc.
 Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Health Technology |
Mylan, Inc.
 Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Health Technology |
CareFusion Corp.
 CareFusion Corp. Medical DistributorsDistribution Services CareFusion Corp. engages in the manufactures of medical equipment and device. The company was founded on February 4, 2009 and is headquartered in San Diego, CA. | Distribution Services |
Mylan NV
 Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Health Technology |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Commercial Services |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Commercial Services |
New York State Society of Certified Public Accountants
New York State Society of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services New York State Society of Certified Public Accountants is a non-profit organization. It provides a membership program for certified public accountants that offers in-person and online networking opportunities, Continuing Professional Education courses and conferences, the CPA Journal, and other publications. The company was foudned in 1897 and is headquartered in New York, NY. | Commercial Services |
Mylan Institutional, Inc.
Mylan Institutional, Inc. Pharmaceuticals: MajorHealth Technology Mylan Institutional, Inc. provides unit dose generic pharmaceuticals to hospitals and other institutions. The firm offers health care equipment and medical line of burn care products. The company was founded in 1980 and is headquartered in Rockford, IL. | Health Technology |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
ConvaTec, Inc.
 ConvaTec, Inc. Medical SpecialtiesHealth Technology ConvaTec, Inc. engages in the manufacture of medical products and technologies focused on therapies for the management of chronic conditions. It specializes in the wound care, ostomy care, continence and critical care, and infusion devices. The company was founded in 1978 and is headquartered in Bridgewater, NJ. | Health Technology |
Advanz Pharma Corp. Ltd.
 Advanz Pharma Corp. Ltd. Pharmaceuticals: MajorHealth Technology ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. The firm specializes in anti-Infectives and endocrinology therapy areas. It operates through the following segments: Advanz Pharma International; Advanz Pharma North America; and Corporate. The Advanz Pharma International segment include portfolio of branded and generic products that are sold to wholesalers, hospitals, and pharmacies. The Advanz Pharma North America segment comprises branded products and authorized generic contracts that focuses primarily on the U.S. pharmaceutical market. The Corporate segment represents the centralized costs. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in St. Helier, the United Kingdom. | Health Technology |
WhereverTV, Inc.
 WhereverTV, Inc. BroadcastingConsumer Services WhereverTV, Inc. operates as an Internet television platform. It delivers a directory of video and music channels, such as sports, news, and entertainment, broadcast live over the internet. The firm’s platform enables subscribers to access licensed and free-to-air content across these devices with the IPG across unlimited geographies, and wherever there is internet connectivity. The company was founded by Mark Cavicchia on July 21, 2006 and is headquartered in Coraopolis, PA. | Consumer Services |
Convatec Healthcare B SARL
 Convatec Healthcare B SARL Medical DistributorsDistribution Services Convatec Healthcare B SARL provides medical products. It also offers continence and critical care products comprising fecal incontinence devices; securement devices to hold tubes, drains and catheters in place on the skin; intermittent catheters and intra-abdominal pressure monitoring devices. The company is headquartered in Luxembourg. | Distribution Services |
Acacia Pharma Group Ltd.
 Acacia Pharma Group Ltd. Pharmaceuticals: OtherHealth Technology Acacia Pharma Group Plc is a holding company, which engages in the development and commercialization of pharmaceutical product. It focuses on the new nausea and vomiting treatments for surgical and cancer patients. The company was founded by Julian Clive Gilbert, Robert William Gristwood, and Andrew Muncey in 2007 and is headquartered in Duxford, the United Kingdom. | Health Technology |
Acacia Pharma Ltd.
Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Nexcella, Inc.
Nexcella, Inc. BiotechnologyHealth Technology Part of Immix Biopharma, Inc., Nexcella, Inc. is a clinical-stage biopharmaceutical company based in Los Angeles, CA. The private company is engaged in the discovery and development of novel cell therapies for oncology and other indications. Nexcella's lead candidate, next generation bcma-targeted car-t nxc-201, has produced high response rates in relapsed/refractory al amyloidosis and relapsed/refractory multiple myeloma, and has been awarded orphan drug designation by the FDA in both indications. The company's n-genius platform allows for the discovery, development, and manufacture of cutting-edge cell therapies for patients in need. Expansion into autoimmune indications is planned. | Health Technology |
